Literature DB >> 15270734

Inhibition of murine allergic airway disease by Bordetella pertussis.

Young-Suk Kim1, Keun-Sang Kwon, Dae-Ki Kim, Il-Whan Choi, Hern-Ku Lee.   

Abstract

Whole-cell pertussis vaccines have been shown to selectively induce T helper 1 (Th1)-type responses in human and animals. In this study, we investigated whether whole-cell B. pertussis could inhibit allergic airway reactions in a murine model of asthma induced by ovalbumin (OVA). Systemic administration of whole-cell B. pertussis strongly inhibited allergic airway reactions such as eosinophil recruitment into the airway, lung inflammation, and airway hyperresponsiveness to methacholine. The inhibitory effect of whole-cell B. pertussis was mediated by chromosomal DNA and pretreatment of DNA with CpG methylase or DNase I resulted in a loss of the inhibitory effect. Treatment of animals with B. pertussis DNA significantly decreased the Th2 cytokine (interleukins IL-4 and IL-5) concentrations in the airways without increasing Th1 cytokines. These results suggest that B. pertussis DNA containing unmethylated CpG appears to be responsible for the inhibitory effect of whole cell B. pertussis on the allergic airway reactions through inhibition of the Th2 response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270734      PMCID: PMC1782536          DOI: 10.1111/j.1365-2567.2004.01880.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Toll-like receptors: key mediators of microbe detection.

Authors:  David M Underhill; Adrian Ozinsky
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 3.  Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates.

Authors:  Daniela Verthelyi; Dennis M Klinman
Journal:  Clin Immunol       Date:  2003-10       Impact factor: 3.969

4.  Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.

Authors:  H Shirota; K Sano; T Kikuchi; G Tamura; K Shirato
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 5.  Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases.

Authors:  Anthony Adam Horner; Eyal Raz
Journal:  J Allergy Clin Immunol       Date:  2002-11       Impact factor: 10.793

6.  Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns.

Authors:  M A Nahori; M Lagranderie; J Lefort; F Thouron; D Joseph; N Winter; B Gicquel; J R Lapa e Silva; B B Vargaftig
Journal:  Vaccine       Date:  2001-01-08       Impact factor: 3.641

7.  CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma.

Authors:  J N Kline; A M Krieg; T J Waldschmidt; Z K Ballas; V Jain; T R Businga
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

Review 8.  DNA-based immunotherapeutics for the treatment of allergic disease.

Authors:  A A Horner; J H Van Uden; J M Zubeldia; D Broide; E Raz
Journal:  Immunol Rev       Date:  2001-02       Impact factor: 12.988

9.  International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema.

Authors:  E von Mutius; N Pearce; R Beasley; S Cheng; O von Ehrenstein; B Björkstén; S Weiland
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

10.  Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice.

Authors:  F Tükenmez; N N Bahçeciler; I B Barlan; M M Başaran
Journal:  Pediatr Allergy Immunol       Date:  1999-05       Impact factor: 6.377

View more
  7 in total

Review 1.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

2.  Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma.

Authors:  T H Harju; M Leinonen; J Nokso-Koivisto; T Korhonen; R Räty; Q He; T Hovi; J Mertsola; A Bloigu; P Rytilä; P Saikku
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

3.  Polyopes affinis alleviates airway inflammation in a murine model of allergic asthma.

Authors:  Dae-Sung Lee; Won Sun Park; Soo-Jin Heo; Seon-Heui Cha; Daekyung Kim; You-Jin Jeon; Sae-Gwang Park; Su-Kil Seo; Jung Sik Choi; Sung-Jae Park; Eun Bo Shim; Il-Whan Choi; Won-Kyo Jung
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

4.  Inhibition of airway allergic disease by co-administration of flagellin with allergen.

Authors:  Shee Eun Lee; Youngil I Koh; Mi-Kwang Kim; Young Ran Kim; Soo Young Kim; Jong Hee Nam; Yoo Duk Choi; Soo Jang Bae; Young Jong Ko; Hwa-Ja Ryu; Jeong Tae Koh; Hyon E Choy; Joon Haeng Rhee
Journal:  J Clin Immunol       Date:  2007-11-17       Impact factor: 8.317

5.  Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury.

Authors:  Hye Ryoun Jang; Maria Teresa Gandolfo; Gang Jee Ko; Shailesh Satpute; Lorraine Racusen; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-12

Review 6.  Effect of barrier microbes on organ-based inflammation.

Authors:  Holger Garn; Joana F Neves; Richard S Blumberg; Harald Renz
Journal:  J Allergy Clin Immunol       Date:  2013-06       Impact factor: 10.793

7.  Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma.

Authors:  Hongyu Qiu; Rhonda Kuolee; Greg Harris; Hongyan Zhou; Harvey Miller; Girishchandra B Patel; Wangxue Chen
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.